Our Mission is to Help Our Members Help Patients

Because Patients Can't Wait®

609-890-3185 | BioNJ@BioNJ.org

Collecting and Connecting the Dots

“Connecting and Collecting the Dots” is a deliverable identified under the overarching BioNJ Health Equity in Clinical Trials Initiative. While many companies in New Jersey want to increase diversity in clinical trials, there is currently no unified platform through which companies can exchange strategies and share their initiatives.

Under “Collecting and Connecting the Dots,” our goal is to create a publicly accessible virtual platform where companies can share their work and projects, industry professionals can find examples from which to learn and collaboration can flourish. Over the coming months, BioNJ will focus on the “Collecting” portion of this initiative – with the goal of having the portal built and populated by the close of 2022.

The “Connecting the Dots” phase will commence at the start of 2023 with a series of virtual and in-person events during which companies will present their initiatives and connect with others for interactive Q&A and to explore collaboration opportunities.

Name Title Company
Naikia Atkinson Director, US Clinical Trials Diversity & Inclusion Sanofi
Patricia Doykos Senior Vice President, Global Policy & Government Affairs Bristol Myers Squibb
Kelly McKee Vice President, Patient Registries & Recruitment Medidata
Nagaraja Srivatsan (Sri)
Debbie Hart President & CEO BioNJ
Randi Bromberg Vice President, Communications and Marketing BioNJ